Human BioSystems
OTC Bulletin Board : HBSC

Human BioSystems

May 03, 2007 07:00 ET

HBS Bioenergy Enters Into a Strategic Land Purchase Agreement for the Construction of an Ethanol Plant and Renewable Energy Park

PALO ALTO, CALIFORNIA--(CCNMatthews - May 3, 2007) - Human BioSystems ("HBS" or "Company") (OTCBB:HBSC) announced today that its wholly owned subsidiary HBS BioEnergy ("HBSE") entered into an agreement to purchase land in the central valley of California for the proposed construction of an ethanol plant. It will utilize proprietary design characteristics to enable the production of low cost ethanol.

Mr. Claude Luster III, President of HBSE, stated that, "Based upon our 'closed-loop' approach which is used extensively in the food processing industry, we anticipate substantial cost reductions in the manufacture of the renewable fuel ethanol. The location is ideal for our purpose to achieve lower cost ethanol than would be possible through traditional processes."

He went on to say, "With rising prices of the raw materials used in the production of ethanol, this cost-mitigating approach enables a very competitive advantage in this marketplace."

"The ability to generate low-cost energy and produce value-added byproducts with our unique approach should generate advantages for the bottom line that will be attractive for our stockholders" said Mr. Harry Masuda, President of HBS.

"With the backdrop of the political climate supporting increases in the national renewable fuel capacity, we feel fortunate to be able to capitalize on manufacturing strengths that we feel will position us advantageously" Mr. Masuda went on to say.

HBS BioEnergy is in the business of utilizing cutting-edge technologies in the biofuels arena. It has assembled a diverse team for the location, development and construction of renewable fuel facilities throughout the United States.

Certain statements contained herein are "forward-looking'' statements (as such term is defined in the Private Securities Litigation Reform Act of 1995). Because such statements include risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the inability of HBS to raise funding for the proposed joint venture projects, failure to consummate the purchase of real property on which the park will be built, failure to obtain regulatory approvals for the construction of the energy park and ethanol plant, failure to obtain the required financing and to construct the energy park and ethanol plant, failure of the energy park and ethanol plant to meet standards, the inability to find raw material for the production of energy and ethanol or to sell the energy and ethanol on acceptable terms, the risks involved in pursuing a business unrelated to HBS' prior business, and other factors discussed in filings made by the Company with the Securities and Exchange Commission.

Contact Information

  • Human BioSystems
    Harry Masuda
    (650) 323-0943
    or
    Yes International
    Investor Relations
    1-800-631-8127